We’ve come a long way since the perseverance and morality of Frances Kelsey. A long way… In the opposite direction.
Read the excerpt below and then follow the links posted at the bottom of this post to find out if the FDA is still that vigorous about protecting pregnant women.
Excerpt from article:
“Marketed as a sedative for pregnant women, thalidomide was already available in Canada, Germany, and several African countries. It could have been a very simple approval. But for Kelsey, something didn’t sit right. There were no tests showing thalidomide was safe for human use, particularly during pregnancy.
“When Chemie Grünenthal released thalidomide in West Germany years earlier, they called it a “wonder drug” for pregnant women. They promised it would treat anxiety, insomnia, tension, and morning sickness and help pregnant women sleep.
What they didn’t advertise were its side effects.
“Because it crosses the placental barrier between fetus and mother, thalidomide causes devastating — often fatal — physical defects. During the five years it was on the market, an estimated 10,000 babies globally were born with thalidomide-caused defects. Only about 60% lived past their first birthday.”
Now, compare to what a pregnant woman today is recommended to ingest and inject:
Pesticides (sprayed in the air, added to water, sprayed on food) also cross the placental barrier. http://www.ncbi.nlm.nih.gov/m/pubmed/19744971/
Mercury (thimerosal – vaccine preservative) crosses the placental barrier. http://www.ncbi.nlm.nih.gov/m/pubmed/22717874/
Aluminum (vaccine adjuvant) crosses the placental barrier. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315392/pdf/nihms229599.pdf
TDaP (recommended for pregnant women today in the US) has not been studied in pregnant women. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5704a1.htm
The flu shot (recommended for pregnant women today in the US) has not been studied in pregnant women. https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Flulaval_Quadrivalent/pdf/FLULAVAL-QUADRIVALENT.PDF